Vyhledat publikace
Chasák, J.; Janicki, I.; Brulíková, L.*
The Liebeskind–Srogl Cross-Coupling Reaction Towards the Synthesis of Biologically Active Compounds
Eur. J. Med. Chem. 2025, 290 (-), 117526. DOI: 10.1016/j.ejmech.2025.117526
Chasák, J.; Brulíková, L.*
Squaramides: New Antituberculosis Agents Effective Against BDQ-Resistant Strains
2nd Blue Danube Ph.D. Symposium, 5th June, 2024, virtual symposium, oral communication .
Chasák, J.; Van Moll, L.; Matheeussen, A.; De Vooght, L.; Cos, P.; Brulíková, L.*
The Liebeskind–Srogl Cross-Coupling Reaction as a Crucial Step in the Synthesis of New Squaramide-Based Antituberculosis Agents
ACS Omega 2024, 9 (32), 34808–34828. DOI: 10.1021/acsomega.4c04314
Chasak, J.; Bruliková, L.*
Solid-Phase Synthesis of Aryl Squaramides Using Liebeskind-Srogl Cross-Coupling as a Crucial Reaction Step
58th Advances in Organic, Bioorganic and Pharmaceutical Chemistry, November 7-9, 2024, Špindlerův mlýn, poster .
Chasák, J.; Oorts, L.; Cos, P.; Brulíková, L.*
Squaramides as Mycobacterial ATP synthase Inhibitors: Synthetic Pathways, Biological Evaluation & Mechanism of Action
20th Blue Danube Symposium, August 25-28, 2024, Prague, oral communication .
Chasák, J.; Oorts, L.; Dak, M.; Šlachtová, V.; Bazgier, V.; Berka, K.; De Vooght, L.; Smiejkowska, N.; Van Calster, K.; Van Moll, L.; Cappoen, D.; Cos, P.; Brulíková, L.*
Expanding the squaramide library as mycobacterial ATP synthase inhibitors: innovative synthetic pathway and biological evaluation
Bioorg. Med. Chem. 2023, 95 (-), 117504(1-18). DOI: 10.1016/j.bmc.2023.117504
Chasák, J.; Brulíková, L.
Synthesis of New Squaric Acid Derivatives with Potential Antituberculosis Activity via Liebeskind-Srogl coupling
Drug Discovery and Selection: 57th International Conference on Medicinal Chemistry, July 5 – 7, 2023, Lille, France, poster .
Chasak, J.; Cos, P; Bruliková, L.*
New Synthetic Approach Employing Liebeskind-Srogl Coupling for Synthesis of Squamides with Potential Antituberculosis Activity
57th Advances in Organic, Bioorganic and Pharmaceutical Chemistry, November 9 – 11, 2023, Špindlerův mlýn, přednáška .
Brulíková, L.; Chasák, J.; Dak, M.; Šlachtová, V.; Cappoen, D.; Šebela, M.; Berka, K.; Bazgier, V.
New agents for the treatment of drug-resistant Mycobacterium tubercculosis
74. sjezd českých a slovenských chemických společností, September 4 – 7, 2022, Olomouc, přednáška .
Chasák, J.; Berka, K.; Bazgier, V.; Cappoen, D.; Brulíková, L.
Squaric acid derivatives as new potential antituberculosis agents
56th Advances in Organic, Bioorganic and Pharmaceutical Chemistry, November 10 – 12, 2022, Špindlerův mlýn, poster .